Literature DB >> 10446152

A beta-tubulin leucine cluster involved in microtubule assembly and paclitaxel resistance.

M L Gonzalez-Garay1, L Chang, K Blade, D R Menick, F Cabral.   

Abstract

Analysis of beta-tubulin alleles from nine paclitaxel-resistant Chinese hamster ovary cell lines revealed an unexpected cluster of mutations affecting Leu-215, Leu-217, and Leu-228. Six of the mutant alleles encode a His, Arg, or Phe substitution at Leu-215; another mutant allele has an Arg substitution at Leu-217; and the final two mutant alleles have substitutions of His or Phe at Leu-228. Using plasmids that allow tetracycline regulated expression, the L215H, L217R, and L228F mutations were introduced into a hemagglutinin antigen-tagged beta-tubulin cDNA and transfected into wild-type Chinese hamster ovary cells. In all three cases, low to moderate expression of the transfected mutant gene conferred paclitaxel resistance. Higher levels of expression caused disruption of microtubule assembly, cell cycle arrest at mitosis, and failure to proliferate. Consistent with reduced microtubule stability, cells expressing mutant hemagglutinin beta-tubulin had fewer acetylated microtubules than nonexpressing cells in the same population. These data, together with previous studies showing that the paclitaxel-resistant mutant cell lines have less stable microtubules, indicate that the leucine cluster represents an important structural motif for microtubule assembly.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10446152     DOI: 10.1074/jbc.274.34.23875

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

Review 1.  Plant tubulins: a melting pot for basic questions and promising applications.

Authors:  D Breviario; P Nick
Journal:  Transgenic Res       Date:  2000-12       Impact factor: 2.788

2.  Effects of Taxotere on invasive potential and multidrug resistance phenotype in pancreatic carcinoma cell line SUIT-2.

Authors:  B Liu; E Staren; T Iwamura; H Appert; J Howard
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

3.  Paclitaxel-dependent cell lines reveal a novel drug activity.

Authors:  Anutosh Ganguly; Hailing Yang; Fernando Cabral
Journal:  Mol Cancer Ther       Date:  2010-10-26       Impact factor: 6.261

Review 4.  Mechanisms of Taxol resistance related to microtubules.

Authors:  George A Orr; Pascal Verdier-Pinard; Hayley McDaid; Susan Band Horwitz
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867

5.  A ubiquitous beta-tubulin disrupts microtubule assembly and inhibits cell proliferation.

Authors:  Rajat Bhattacharya; Fernando Cabral
Journal:  Mol Biol Cell       Date:  2004-04-30       Impact factor: 4.138

6.  Insights into the mechanism of microtubule stabilization by Taxol.

Authors:  Hui Xiao; Pascal Verdier-Pinard; Narcis Fernandez-Fuentes; Berta Burd; Ruth Angeletti; Andras Fiser; Susan Band Horwitz; George A Orr
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-26       Impact factor: 11.205

7.  Taxol allosterically alters the dynamics of the tubulin dimer and increases the flexibility of microtubules.

Authors:  Arpita Mitra; David Sept
Journal:  Biophys J       Date:  2008-07-11       Impact factor: 4.033

8.  Molecular basis for class V beta-tubulin effects on microtubule assembly and paclitaxel resistance.

Authors:  Rajat Bhattacharya; Fernando Cabral
Journal:  J Biol Chem       Date:  2009-03-12       Impact factor: 5.157

9.  Acetylated tubulin (AT) as a prognostic marker in squamous cell carcinoma of the head and neck.

Authors:  Nabil F Saba; Kelly R Magliocca; Sungjin Kim; Susan Muller; Zhengjia Chen; Taofeek K Owonikoko; Nicholas J Sarlis; Carrie Eggers; Vanessa Phelan; William J Grist; Amy Y Chen; Suresh S Ramalingam; Zhuo G Chen; Jonathan J Beitler; Dong M Shin; Fadlo R Khuri; Adam I Marcus
Journal:  Head Neck Pathol       Date:  2013-07-24

Review 10.  Can the status of the breast and ovarian cancer susceptibility gene 1 product (BRCA1) predict response to taxane-based cancer therapy?

Authors:  J Thomas De Ligio; Aneliya Velkova; Diego A R Zorio; Alvaro N A Monteiro
Journal:  Anticancer Agents Med Chem       Date:  2009-06       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.